Disc Medicine, Inc. (IRON) Net Income (Loss) Attributable to Parent USD 2020 - 2024

Historical data

Taxonomy & unit
us-gaap: USD
Description
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
Summary
Disc Medicine, Inc. quarterly/annual Net Income (Loss) Attributable to Parent history and growth rate from 2020 to 2024.
  • Disc Medicine, Inc. Net Income (Loss) Attributable to Parent for the quarter ending March 31, 2024 was -$26.9 M, a 18.3% decline year-over-year.
  • Disc Medicine, Inc. Net Income (Loss) Attributable to Parent for the twelve months ending March 31, 2024 was -$80.6 M, a 34.9% decline year-over-year.
  • Disc Medicine, Inc. annual Net Income (Loss) Attributable to Parent for 2023 was -$76.4 M, a 63.2% decline from 2022.
  • Disc Medicine, Inc. annual Net Income (Loss) Attributable to Parent for 2022 was -$46.8 M, a 30.2% decline from 2021.
  • Disc Medicine, Inc. annual Net Income (Loss) Attributable to Parent for 2021 was -$36 M, a 11.9% increase from 2020.
Net Income (Loss) Attributable to Parent, Trailing 12 Months (USD)
Net Income (Loss) Attributable to Parent, Quarterly (USD)
Net Income (Loss) Attributable to Parent, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q1 2024 -$80.6 M -$26.9 M -$4.17 M -18.3% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-09
Q4 2023 -$76.4 M -$23.6 M -$12.3 M -110% Oct 1, 2023 Dec 31, 2023 10-K 2024-03-21
Q3 2023 -$64.1 M -$14.1 M +$2.03 M +12.6% Jul 1, 2023 Sep 30, 2023 10-Q 2023-11-09
Q2 2023 -$66.1 M -$15.9 M -$6.37 M -66.5% Apr 1, 2023 Jun 30, 2023 10-Q 2023-11-09
Q1 2023 -$59.8 M -$22.8 M -$12.9 M -131% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-09
Q4 2022 -$46.8 M -$11.2 M -$29.3 M -162% Oct 1, 2022 Dec 31, 2022 10-K 2024-03-21
Q3 2022 -$17.5 M -$16.2 M +$2.4 M +12.9% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-09
Q2 2022 -$19.9 M -$9.58 M +$6.87 M +41.8% Apr 1, 2022 Jun 30, 2022 10-Q 2023-11-09
Q1 2022 -$26.8 M -$9.85 M +$9.2 M +48.3% Jan 1, 2022 Mar 31, 2022 10-Q 2023-11-09
Q4 2021 -$36 M $18.1 M +$32.4 M Oct 1, 2021 Dec 31, 2021 10-K 2023-03-31
Q3 2021 -$68.4 M -$18.6 M -$8.55 M -85.5% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-10
Q2 2021 -$59.8 M -$16.4 M -$9.67 M -143% Apr 1, 2021 Jun 30, 2021 10-Q 2022-11-10
Q1 2021 -$50.1 M -$19 M -$9.3 M -95.4% Jan 1, 2021 Mar 31, 2021 10-Q 2022-11-10
Q4 2020 -$40.8 M -$14.3 M Oct 1, 2020 Dec 31, 2020 10-K 2022-03-10
Q3 2020 -$10 M Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-15
Q2 2020 -$6.77 M Apr 1, 2020 Jun 30, 2020 10-Q 2021-11-15
Q1 2020 -$9.75 M Jan 1, 2020 Mar 31, 2020 10-Q 2021-11-15
* An asterisk sign (*) next to the value indicates that the value is likely invalid.